Page results
-
A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.
-
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
-
Read more about the award for researcher behind first treatment for rare disease
-
The Government has now set out further action aimed at tackling rising cases of the COVID-19 B1.617.2 variant of COVID-19 (also known as the Indian variant).
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.
-
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
The court has granted permission to appeal a High Court ruling relating to puberty-blocking treatment in cases of gender dysphoria.
-
A study has shed light on multiple factors in the recruitment process in research that act as barriers to the recruitment of patients from minority ethnic groups to trials.
-
At UCLH, we are extremely proud of our staff and their dedication to delivering the best care for our patients. If you have been treated or looked after by an exceptional member of staff, or a volunteer, we would love you to tell us about it.
File results
-
Patient daily headache diary
-
Patient telephone reminder service opt-out form
-
Living with sickle cell disorder guide for patients
-
-
FOI/2023/0820 - Antenatal classes offered in person and online
-
FOI/2021/0040 - Trust's online clinic/video consultation system
-
FOI/2020/0653 - Contract/ framework/ tender used to buy microcatheters
-
FOI/2023/0825 - Treatments for any disease, Berinert, Cinryze, Orladeyo etc/ hereditary angioedema (HAE)
-
-